Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin vs Lidocaine for Masticatory Myofascial Pain
NCT00992108Phase 4Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in myofascial pain syndrome (MPS), sponsored by University of California, Los Angeles. Started Oct 2009; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT00992108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992108.